McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

acquisition

04/02/2025 - 08:00 AM

Announces fourth quarter and full year fiscal 2025 earnings release date

IRVING, Texas--(BUSINESS WIRE)-- McKesson Corporation (NYSE: MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC, a leading provider of general ophthalmology and retina management services.

McKesson acquired an approximate 80% controlling interest in PRISM Vision Holdings, an ophthalmology and retina management services provider, for about $850 million. PRISM physicians will retain an approximate 20% interest. The acquisition enables McKesson to develop a leading retinal and ophthalmology platform and expand McKesson’s differentiated value proposition, clinical services and distribution offerings.

Additionally, McKesson will release its fourth quarter and full year fiscal 2025 financial results after market close on Thursday, May 8, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

The live webcast will be available on McKesson’s Investor Relations website at investor.mckesson.com, along with the company’s earnings release, financial tables and slide presentation.

About McKesson Corporation

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.

Cautionary Statement

Except for historical information, statements in this press release regarding McKesson’s acquisition and related arrangements constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve risks and uncertainties that could cause actual results to differ materially from those in those statements. It is not possible to identify all such risks and uncertainties. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly update forward-looking statements. We encourage investors to read the important risk factors described in the company’s most recent Form 10-K filed with the Securities and Exchange Commission. These risk factors include, but are not limited to: we may not achieve expected outcomes from the transaction; we might be adversely impacted by delays or other difficulties; we from time to time record significant charges from impairment to goodwill, intangibles and other assets or investments; we might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events, economic events and other catastrophic events.